UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif

Clinical and translational gastroenterology, 2023-12, Vol.14 (12), p.e00607-e00607

2023

Volltextzugriff (PDF)

SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction

Bulletin du cancer, 2012-02, Vol.99 (2), p.E1-E9

2012

Volltextzugriff (PDF)

External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab

Pharmaceutics, 2021-08, Vol.13 (8), p.1191

2021

Volltextzugriff (PDF)

Histological Indices and Risk of Recurrence in Crohn’s Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission

Inflammatory bowel diseases, 2022-09, Vol.28 (9), p.1395-1404

2022

Volltextzugriff (PDF)

Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors

Endocrine, 2022-11, Vol.78 (2), p.380-386

2022

Volltextzugriff (PDF)

Ustekinumab for skin reactions associated with anti‐tumor necrosis factor‐α agents in patients with inflammatory bowel diseases: A single‐center retrospective study

Journal of dermatology, 2019-04, Vol.46 (4), p.322-327

2019

Volltextzugriff (PDF)

Sunitinib achieved fast and sustained control of VIPoma symptoms

European journal of endocrinology, 2015-01, Vol.172 (1), p.K1

2015

Volltextzugriff (PDF)

Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases

Journal of medical virology, 2010-10, Vol.82 (10), p.1694-1700

2010

Volltextzugriff (PDF)

Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study

Journal of the American Academy of Dermatology, 2014-06, Vol.70 (6), p.1146-1149

2014

Volltextzugriff (PDF)

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy

Inflammatory bowel diseases, 2016-06, Vol.22 (6), p.1362-1369

2016

Volltextzugriff (PDF)

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

Digestive diseases and sciences, 2022-09, Vol.67 (9), p.4525-4532

2022

Volltextzugriff (PDF)

Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms

Endocrine Connections, 2022-11, Vol.11 (11), p.1-8

2022

Volltextzugriff (PDF)

Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID

Clinical and translational gastroenterology, 2023-08, Vol.14 (12)

2023

Volltextzugriff (PDF)

Three‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi‐centre cohort study

Alimentary Pharmacology & Therapeutics (Suppl), 2019-07, Vol.50 (1), p.40-53

2019

Volltextzugriff (PDF)

Virological Diagnosis of Herpes Simplex Virus 1 Esophagitis by Quantitative Real-Time PCR Assay

Journal of Clinical Microbiology, 2012-03, Vol.50 (3), p.948-952

2012

Volltextzugriff (PDF)

Updating the management of patients with rectal neuroendocrine tumors

Endoscopy, 2013-12, Vol.45 (12), p.1039

2013

Volltextzugriff (PDF)

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (5), p.588-595

2018

Volltextzugriff (PDF)

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2013-07, Vol.145 (1), p.166-175.e8

2013

Volltextzugriff (PDF)

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis

Clinical gastroenterology and hepatology, 2019-02, Vol.17 (3), p.494-501

2019

Volltextzugriff (PDF)

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

Clinical gastroenterology and hepatology, 2016-02, Vol.14 (2), p.242-250.e2

2016

Volltextzugriff (PDF)

Small Intestinal Neuroendocrine Neoplasm: Factors Associated with the Development of Local Tumor-Related Symptoms

Neuroendocrinology, 2022-03, Vol.112 (3), p.252-262

2022

Volltextzugriff (PDF)

Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors

Clinical nuclear medicine, 2022-04, Vol.47 (4), p.294

2022

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(73)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif

SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction

External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab

Histological Indices and Risk of Recurrence in Crohn’s Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission

Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors

Ustekinumab for skin reactions associated with anti‐tumor necrosis factor‐α agents in patients with inflammatory bowel diseases: A single‐center retrospective study

Sunitinib achieved fast and sustained control of VIPoma symptoms

Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases

Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms

Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID

Three‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi‐centre cohort study

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Virological Diagnosis of Herpes Simplex Virus 1 Esophagitis by Quantitative Real-Time PCR Assay

Updating the management of patients with rectal neuroendocrine tumors

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

Small Intestinal Neuroendocrine Neoplasm: Factors Associated with the Development of Local Tumor-Related Symptoms

Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

Suchergebnisse filtern